1. Home
  2. QUIK vs ACHV Comparison

QUIK vs ACHV Comparison

Compare QUIK & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$20.19

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$5.12

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
ACHV
Founded
1988
N/A
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
172.0M
IPO Year
1997
2018

Fundamental Metrics

Financial Performance
Metric
QUIK
ACHV
Price
$20.19
$5.12
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$11.00
$14.67
AVG Volume (30 Days)
648.0K
1.4M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
N/A
Revenue This Year
$75.17
N/A
Revenue Next Year
$16.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$2.00
52 Week High
$24.33
$6.15

Technical Indicators

Market Signals
Indicator
QUIK
ACHV
Relative Strength Index (RSI) 52.12 53.31
Support Level $5.92 $4.04
Resistance Level $23.24 $5.30
Average True Range (ATR) 1.81 0.38
MACD -0.21 -0.02
Stochastic Oscillator 45.35 56.82

Price Performance

Historical Comparison
QUIK
ACHV

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Share on Social Networks: